|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.4234 USD | +0.47% |
|
+4.00% | -79.25% |
| 14/05 | Transcript : The Oncology Institute, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
| 14/05 | The Oncology Institute, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
The Oncology Institute, Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported revenue was USD 94.67 million compared to USD 76.19 million a year ago. Net loss was USD 19.89 million compared to USD 30 million a year ago.
Basic loss per share from continuing operations was USD 0.22 compared to USD 0.33 a year ago. Diluted loss per share from continuing operations was USD 0.22 compared to USD 0.33 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -79.25% | 3.15Cr | |
| +25.78% | 8.92TCr | |
| -23.45% | 7.59TCr | |
| +2.61% | 2.74TCr | |
| -8.56% | 1.75TCr | |
| +1.39% | 1.7TCr | |
| +0.30% | 1.54TCr | |
| +78.55% | 1.32TCr | |
| +77.76% | 1.37TCr | |
| -25.79% | 1.28TCr |
THE ONCOLOGY INSTITUTE, INC. 
